meglumine and Liver Dysfunction

meglumine has been researched along with Liver Dysfunction in 65 studies

Research

Studies (65)

Timeframe	Studies, this research(%)	All Research%
pre-1990	2 (3.08)	18.7374
1990's	23 (35.38)	18.2507
2000's	14 (21.54)	29.6817
2010's	24 (36.92)	24.3611
2020's	2 (3.08)	2.80

Authors

Authors	Studies
Cai, S; Lin, N; Lin, X; Ma, W; Wang, X; Wang, Y; Yang, Y; Zhao, X	1
Hull, NC; Lee, EY; Schooler, GR	1
Chang, SD; Harris, AC; Scali, EP; Tiwari, HA; Walshe, T	1
Dong, YH; Guo, BL; Hu, QG; Lian, ZY; Luo, XN; Ouyang, FS; Zhang, B; Zhang, SX	1
Bruno, O; Ciolina, M; Di Martino, M; Pommier, R; Ronot, M; Vilgrain, V	1
Dahi, F; Jiang, Y; Oto, A; Rist, C; Schmid-Tannwald, C; Sethi, I	1
Choi, D; Jeong, WK; Kim, YK; Lim, HK; Song, KD	1
Bashir, MR; Burke, LM; Jaffe, TA; Marin, D; Pietryga, JA	1
Bakshi, D; Chang, SD; Diwakar, H; Harris, AC; Homayoon, B; Strovski, E; Thoeni, RF	1
AlObaidy, M; Altun, E; Busireddy, KK; Liu, B; Ramalho, M; Semelka, RC	1
Bannas, P; Bookwalter, CA; Motosugi, U; Reeder, SB; Sano, K	1
Chartrand, G; de Guise, JA; Gotra, A; Massicotte-Tisluck, K; Tang, A; Vandenbroucke-Menu, F; Vu, KN	1
Akata, D; Karcaaltincaba, M; Ünal, E	1
De Becker, J; Hong, HS; Kanematsu, M; Kim, HS; Kim, MJ; Mitchell, DG	1
Altun, E; Herédia, V; Ramalho, M; Semelka, RC; Tsurusaki, M	1
Choi, BI; Han, JK; Kang, WJ; Kim, MA; Kim, SH; Kim, WH; Kim, YH; Youn, SH	1
Catalano, OA; Hahn, PF; Sahani, DV; Saini, S; Seale, MK	1
Cha, SW; Kim, H; Kim, KW; Kim, MJ; Lim, JS; Park, MS; Yoo, HS	1
Bondioni, MP; Faccioli, N; Gambarini, S; Grazioli, L; Kirchin, M; Schneider, G; Tinti, R	1
Boll, DT; Chea, YW; Dale, BM; Merkle, EM; Neville, AM; Samei, E; Wang, CL	1
Bondioni, MP; Faccioli, N; Grazioli, L; Guarise, A; Kirchin, MA; Morana, G; Schneider, G	1
Akata, D; Akhan, O; Akpinar, E; Balli, O; Karcaaltincaba, M; Tirnaksiz, B; Turkbey, B	1
Boll, DT; Feuerlein, S; Gupta, RT; Merkle, EM	1
Brown, JJ; Fowler, KJ; Narra, VR	1
Brismar, TB; Dahlqvist Leinhard, O; Dahlström, N; Kihlberg, J; Lundberg, P; Sandström, P; Smedby, O	1
Dobson, JE; Goodwin, MD; Lim, BG; Sirlin, CB; Stella, DL	1
Angelelli, G; Ficco, M; Lorusso, F; Maggialetti, N; Moschetta, M; Sabbà, C; Scardapane, A; Stabile Ianora, AA; Suppressa, P	1
Brown, JJ; Frydrychowicz, A; Lubner, MG; Merkle, EM; Nagle, SK; Reeder, SB; Rofsky, NM	1
Koh, DM	1
Reimer, P; Schima, W; Schneider, G	1
Gaffke, G; Gnauck, M; Lopez-Häninnen, E; Streitparth, F; Stroszczynski, C; Wieners, G	1
Arduini, F; Cantisani, V; Filpo, M; Laghi, A; Pacella, S; Pagliara, E; Paolantonio, P; Pasqualini, V; Passariello, R; Ricci, P; Trippa, F	1
Al-Abadi, H; Cho, CH; Felix, R; Hengst, S; Lopez Hänninen, E; Lüdemann, L; Mohnike, K; Pech, M; Ricke, J; Seidensticker, M; Wieners, G; Wust, P	1
Claussen, CD; Decker, U; Dietz, K; Müller-Schimpfle, M; Pereira, PL; Schick, F; Wersebe, A; Wiskirchen, J	1
An, SK; Choi, BI; Han, JK; Kim, SH; Kim, YJ; Lee, JM; Lee, NJ; Suh, KS	1
Bayrak, IK; Danaci, M; Diren, HB; Gokce, E; Nural, MS	1
Guarise, A; Morana, G; Salviato, E	1
Bompiani, C; Rossi, P; Rovighi, L; Simonetti, G; Tipaldi, L	1
Pirovano, G; Rosati, G; Spinazzi, A	1
Arakawa, A; Hatanaka, Y; Matsukawa, T; Miyazaki, T; Takahashi, M; Yamamoto, H; Yamashita, Y	1
Baudouin, CJ; Ridgway, JP; Robinson, PJ; Rodgers, PM; Ward, J	1
Bernardino, ME; Gould, RG; Hamm, B; Lüning, M; Mahfouz, AE; Saini, S; Taupitz, M; Thoeni, RF; Wolf, KJ	1
Foo, TK; Francis, IR; Glazer, GM; Herfkens, RJ; Jeffrey, RB; Low, RN; Pelc, NJ; Shimakawa, A	1
Mitchell, DG; Mohamed, F; Ortega, H; Tascyian, T; Vinitski, S	1
Giovagnoni, A; Paci, E	1
Pezzoli, C; Pirovano, G; Ratcliffe, G; Rosati, G; Spinazzi, A	1
Awaya, H; Fujita, T; Honjo, K; Ito, K; Koike, S; Matsumoto, T; Matsunaga, N; Mitchell, DG; Takano, K	1
DeCorato, DR; Earls, JP; Krinsky, GA; Rofsky, NM; Weinreb, JC	1
Blakeborough, A; Griffiths, M; Guthrie, JA; Kajiya, Y; Robinson, PJ; Ward, J; Wilson, D	1
Atilla, S; Borrello, JA; Brown, JJ; Pilgram, TK; Quillin, SP; Yu, CY	1
Gouhiri, M; Rondeau, Y; Rymer, R; Scherrer, A; Soyer, P; Spelle, L	1
Araki, T; Hachiya, J; Haradome, H; Ichikawa, T; Nitatori, T	1
Davies, A; Kirchin, M; Lorusso, V; Pirovano, G; Spinazzi, A; Taroni, P	1
Kirchin, MA; Pirovano, GP; Spinazzi, A	1
Kirchin, M; Lorusso, V; Pirovano, G; Spinazzi, A	1
Clément, O; Cuénod, CA; Frija, G; Leconte, I; Siauve, N; Vuillemin-Bodaghi, V	1
Grazioli, L; Kirchin, M; Pirovano, G; Spinazzi, A	1
de Haën, C; La Ferla, R; Maggioni, F	1
Kenney, CM; Runge, VM	1
De Cobelli, F; De Gaspari, A; Del Maschio, A	1
Bensel, K; Davies, A; Davies, BE; Kirchin, MA; Lafrance, ND; Lorusso, V; Parker, JR	1
Evens, RG; Koehler, RE; Stanley, RJ	1
Eibl-Eibesfeldt, B; Hammerstingl, R; Lissner, J; Peqios, W; Schnell, B; Vogl, TJ	1
Peters, PE; Rummeny, EJ	1
Runge, VM	1

Reviews

17 review(s) available for meglumine and Liver Dysfunction

Article	Year
Hepatobiliary MRI Contrast Agents: Pattern Recognition Approach to Pediatric Focal Hepatic Lesions. AJR. American journal of roentgenology, 2020, Volume: 214, Issue:5 Topics: Child; Contrast Media; Gadolinium DTPA; Humans; Imaging, Three-Dimensional; Liver Diseases; Magnetic Resonance Imaging; Meglumine; Organometallic Compounds; Pattern Recognition, Automated	2020
A Pictorial Review of Hepatobiliary Magnetic Resonance Imaging With Hepatocyte-Specific Contrast Agents: Uses, Findings, and Pitfalls of Gadoxetate Disodium and Gadobenate Dimeglumine. Canadian Association of Radiologists journal = Journal l'Association canadienne des radiologistes, 2017, Volume: 68, Issue:3 Topics: Contrast Media; Gadolinium DTPA; Hepatocytes; Humans; Image Enhancement; Liver Diseases; Magnetic Resonance Imaging; Meglumine; Organometallic Compounds	2017
The MR imaging diagnosis of liver diseases using gadoxetic acid: emphasis on hepatobiliary phase. Clinical and molecular hepatology, 2013, Volume: 19, Issue:4 Topics: Carcinoma, Hepatocellular; Cholangiocarcinoma; Contrast Media; Hemangioma; Humans; Liver Diseases; Liver Neoplasms; Magnetic Resonance Imaging; Meglumine; Organometallic Compounds; Radiography	2013
Liver Function Assessment by Magnetic Resonance Imaging. Seminars in ultrasound, CT, and MR, 2016, Volume: 37, Issue:6 Topics: Contrast Media; Gadolinium DTPA; Humans; Image Enhancement; Liver Diseases; Liver Function Tests; Magnetic Resonance Imaging; Meglumine; Organometallic Compounds	2016
Clinical applications of gadobenate dimeglumine-enhanced magnetic resonance cholangiography: an expanded pictorial review. Japanese journal of radiology, 2011, Volume: 29, Issue:1 Topics: Biliary Tract Diseases; Cholangiopancreatography, Magnetic Resonance; Contrast Media; Humans; Liver Diseases; Meglumine; Organometallic Compounds	2011
Magnetic resonance imaging of focal liver lesions: approach to imaging diagnosis. Hepatology (Baltimore, Md.), 2011, Volume: 54, Issue:6 Topics: Adenoma, Liver Cell; Carcinoma, Hepatocellular; Cholangiocarcinoma; Contrast Media; Diffusion Magnetic Resonance Imaging; Focal Nodular Hyperplasia; Gadolinium DTPA; Hemangioma; Hepatocytes; Humans; Incidental Findings; Liver; Liver Diseases; Liver Neoplasms; Magnetic Resonance Imaging; Meglumine; Organometallic Compounds	2011
Diagnostic challenges and pitfalls in MR imaging with hepatocyte-specific contrast agents. Radiographics : a review publication of the Radiological Society of North America, Inc, 2011, Volume: 31, Issue:6 Topics: Contrast Media; Diagnosis, Differential; Gadolinium DTPA; Hepatocytes; Humans; Liver Diseases; Magnetic Resonance Imaging; Meglumine; Organometallic Compounds	2011
Hepatobiliary MR imaging with gadolinium-based contrast agents. Journal of magnetic resonance imaging : JMRI, 2012, Volume: 35, Issue:3 Topics: Bile Duct Diseases; Contrast Media; Gadolinium DTPA; Humans; Liver Diseases; Magnetic Resonance Imaging; Meglumine; Organometallic Compounds	2012
Hepatobiliary contrast agents for contrast-enhanced MRI of the liver: properties, clinical development and applications. European radiology, 2004, Volume: 14, Issue:4 Topics: Contrast Media; Edetic Acid; Gadolinium; Gadolinium DTPA; Humans; Liver; Liver Diseases; Liver Neoplasms; Magnetic Resonance Imaging; Manganese; Meglumine; Organometallic Compounds; Pyridoxal Phosphate; Time Factors; Tomography, X-Ray Computed	2004
[Current status of MRI diagnostics with liver-specific contrast agents. Gd-EOB-DTPA and Gd-BOPTA]. Der Radiologe, 2004, Volume: 44, Issue:12 Topics: Chelating Agents; Contrast Media; Gadolinium DTPA; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Liver; Liver Diseases; Magnetic Resonance Imaging; Meglumine; Organometallic Compounds; Practice Patterns, Physicians'; Reproducibility of Results; Sensitivity and Specificity	2004
Contrast agents for hepatic MRI. Cancer imaging : the official publication of the International Cancer Imaging Society, 2007, Oct-01, Volume: 7 Spec No A Topics: Contrast Media; Dextrans; Diagnosis, Differential; Ferrosoferric Oxide; Gadolinium DTPA; Humans; Iron; Liver Diseases; Magnetic Resonance Imaging; Magnetite Nanoparticles; Meglumine; Organometallic Compounds; Oxides	2007
Liver. III: Gadolinium-based hepatobiliary contrast agents (Gd-EOB-DTPA and Gd-BOPTA/Dimeg). Magnetic resonance imaging clinics of North America, 1996, Volume: 4, Issue:1 Topics: Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Contrast Media; Female; Gadolinium; Gadolinium DTPA; Humans; Liver; Liver Diseases; Liver Neoplasms; Magnetic Resonance Imaging; Male; Meglumine; Multicenter Studies as Topic; Organometallic Compounds; Pentetic Acid; Safety	1996
Gadobenate dimeglumine (Gd-BOPTA). An overview. Investigative radiology, 1998, Volume: 33, Issue:11 Topics: Animals; Central Nervous System Diseases; Contrast Media; Gadolinium; Heart Diseases; Humans; Liver Diseases; Magnetic Resonance Angiography; Meglumine; Organometallic Compounds	1998
Mechanisms of action of liver contrast agents: impact for clinical use. Journal of computer assisted tomography, 1999, Volume: 23 Suppl 1 Topics: Contrast Media; Dextrans; Edetic Acid; Ferrosoferric Oxide; Gadolinium; Humans; Injections, Intravenous; Iron; Kupffer Cells; Liver; Liver Diseases; Magnetic Resonance Imaging; Magnetite Nanoparticles; Manganese; Meglumine; Organometallic Compounds; Oxides; Pyridoxal Phosphate	1999
Gadobenate dimeglumine 0.5 M solution for injection (MultiHance) as contrast agent for magnetic resonance imaging of the liver: mechanistic studies in animals. Journal of computer assisted tomography, 1999, Volume: 23 Suppl 1 Topics: Animals; Biological Transport; Contrast Media; Diagnosis, Differential; Disease Models, Animal; Gadolinium; Injections, Intravenous; Liver; Liver Diseases; Magnetic Resonance Imaging; Meglumine; Organometallic Compounds	1999
[Magnetic resonance imaging of the liver: what kind of contrast agents?]. La Radiologia medica, 2001, Volume: 102, Issue:3 Topics: Contrast Media; Dextrans; Edetic Acid; Ferrosoferric Oxide; Focal Nodular Hyperplasia; Gadolinium DTPA; Humans; Iron; Liver Diseases; Liver Neoplasms; Magnetic Resonance Imaging; Magnetite Nanoparticles; Meglumine; Organometallic Compounds; Oxides; Pyridoxal Phosphate	2001
[Status and development of new clinical contrast media for MR diagnosis of liver diseases]. Der Radiologe, 1992, Volume: 32, Issue:5 Topics: Acetates; Contrast Media; Edetic Acid; Gadolinium DTPA; Humans; Liver Diseases; Liver Neoplasms; Magnetic Resonance Imaging; Meglumine; Organometallic Compounds; Pentetic Acid; Pyridoxal Phosphate	1992

Trials

7 trial(s) available for meglumine and Liver Dysfunction

Article	Year
Focal liver lesions: whether a standard dose (0.05 mmol/kg) gadobenate dimeglumine can provide the same diagnostic data as the 0.1 mmol/kg dose. European journal of radiology, 2008, Volume: 66, Issue:1 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Contrast Media; Female; Humans; Liver Diseases; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Statistics, Nonparametric	2008
Interim results of phase II clinical testing of gadobenate dimeglumine. Investigative radiology, 1994, Volume: 29 Suppl 2 Topics: Adult; Brain Diseases; Contrast Media; Humans; Liver Diseases; Magnetic Resonance Imaging; Meglumine; Myocardial Infarction; Organometallic Compounds; Single-Blind Method	1994
Safety, tolerance, biodistribution, and MR imaging enhancement of the liver with gadobenate dimeglumine: results of clinical pharmacologic and pilot imaging studies in nonpatient and patient volunteers. Academic radiology, 1999, Volume: 6, Issue:5 Topics: Adult; Aged; Contrast Media; Dose-Response Relationship, Drug; Female; Humans; Liver; Liver Diseases; Liver Neoplasms; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Pilot Projects; Single-Blind Method	1999
MultiHance in the dynamic phase of contrast enhancement: a pictorial assessment. Journal of computer assisted tomography, 1999, Volume: 23 Suppl 1 Topics: Adenoma; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Carcinoma, Hepatocellular; Cholangiocarcinoma; Contrast Media; Diagnosis, Differential; Focal Nodular Hyperplasia; Gadolinium; Hemangioma; Humans; Injections, Intravenous; Liver Diseases; Liver Neoplasms; Magnetic Resonance Imaging; Meglumine; Organometallic Compounds; Prospective Studies	1999
Phase II double-blind, dose-ranging clinical evaluation of gadobenate dimeglumine in focal liver lesions: with analysis of liver and kidney signal change on early and delayed imaging. Journal of magnetic resonance imaging : JMRI, 2000, Volume: 11, Issue:6 Topics: Adult; Aged; Aged, 80 and over; Analysis of Variance; Contrast Media; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Image Enhancement; Liver; Liver Diseases; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Probability; Sensitivity and Specificity; Time Factors	2000
Pharmacokinetics and safety of gadobenate dimeglumine (multihance) in subjects with impaired liver function. Investigative radiology, 2002, Volume: 37, Issue:5 Topics: Adult; Contrast Media; Double-Blind Method; Female; Gadolinium; Humans; Liver; Liver Diseases; Male; Meglumine; Middle Aged; Organometallic Compounds	2002
[Magnetic resonance tomography of the hepatobiliary system: indications, limitations and outlook]. Bildgebung = Imaging, 1992, Volume: 59, Issue:4 Topics: Biliary Tract Diseases; Biliary Tract Neoplasms; Cholangiography; Contrast Media; Edetic Acid; Gadolinium DTPA; Humans; Liver Diseases; Liver Neoplasms; Magnetic Resonance Imaging; Meglumine; Organometallic Compounds; Pentetic Acid; Pyridoxal Phosphate	1992

Other Studies

41 other study(ies) available for meglumine and Liver Dysfunction

Article	Year
The value of contrast-enhanced portal vein imaging at the hepatobiliary phase obtained with gadobenate dimeglumine for predicting decompensation and transplant-free survival in chronic liver disease. European radiology, 2023, Volume: 33, Issue:5 Topics: Contrast Media; End Stage Liver Disease; Gadolinium DTPA; Humans; Liver Cirrhosis; Liver Diseases; Magnetic Resonance Imaging; Meglumine; Organometallic Compounds; Portal Vein; Retrospective Studies; Severity of Illness Index	2023
CT and MRI findings in focal eosinophilic infiltration of the liver. Abdominal radiology (New York), 2017, Volume: 42, Issue:12 Topics: Adolescent; Adult; Aged; Child; Child, Preschool; Contrast Media; Eosinophilia; Female; Humans; Infant; Iohexol; Liver Diseases; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Retrospective Studies; Tomography, X-Ray Computed	2017
Peritoneal and pleural fluids may appear hyperintense on hepatobiliary phase using hepatobiliary MR contrast agents. European radiology, 2018, Volume: 28, Issue:7 Topics: Adult; Aged; Ascitic Fluid; Contrast Media; Female; Gadolinium DTPA; Humans; Image Interpretation, Computer-Assisted; Liver Diseases; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Pleural Effusion; Retrospective Studies	2018
Diffusion-weighted MR imaging of focal liver lesions in the left and right lobes: is there a difference in ADC values? Academic radiology, 2013, Volume: 20, Issue:4 Topics: Adult; Aged; Contrast Media; Diffusion Magnetic Resonance Imaging; Female; Gadolinium; Gadolinium DTPA; Humans; Liver; Liver Diseases; Liver Neoplasms; Male; Meglumine; Middle Aged; Organometallic Compounds	2013
Respiratory motion artifact affecting hepatic arterial phase imaging with gadoxetate disodium: examination recovery with a multiple arterial phase acquisition. Radiology, 2014, Volume: 271, Issue:2 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Artifacts; Contrast Media; Female; Gadolinium DTPA; Hepatic Artery; Humans; Imaging, Three-Dimensional; Liver Diseases; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Respiration; Retrospective Studies; Risk Factors	2014
Half-dose gadobenate dimeglumine versus standard-dose gadodiamide in dynamic magnetic resonance imaging of non-cirrhotic livers: a retrospective intra-individual crossover comparison. Abdominal imaging, 2014, Volume: 39, Issue:5 Topics: Contrast Media; Cross-Over Studies; Female; Gadolinium DTPA; Humans; Image Enhancement; Liver; Liver Diseases; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Retrospective Studies	2014
Quantitative and qualitative comparison of 0.025 mmol/kg gadobenate dimeglumine for abdominal MRI at 1.5T and 3T MRI in patients with low estimated glomerular filtration rate. European journal of radiology, 2015, Volume: 84, Issue:1 Topics: Abdomen; Adult; Contrast Media; Female; Glomerular Filtration Rate; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Kidney; Liver Diseases; Longitudinal Studies; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Pancreatic Diseases; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity	2015
An Investigation of Transient Severe Motion Related to Gadoxetic Acid-enhanced MR Imaging. Radiology, 2016, Volume: 279, Issue:1 Topics: Adult; Aged; Artifacts; Contrast Media; Dyspnea; Female; Gadolinium DTPA; Humans; Japan; Liver Diseases; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Movement; Organometallic Compounds; Prospective Studies; United States	2016
Comparison of MRI- and CT-based semiautomated liver segmentation: a validation study. Abdominal radiology (New York), 2017, Volume: 42, Issue:2 Topics: Contrast Media; Cross-Sectional Studies; Female; Humans; Image Interpretation, Computer-Assisted; Imaging, Three-Dimensional; Liver Diseases; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organ Size; Organometallic Compounds; Pancreatic Diseases; Reproducibility of Results; Retrospective Studies; Tomography, X-Ray Computed	2017
Single breath-hold multiarterial dynamic MRI of the liver at 3T using a 3D fat-suppressed keyhole technique. Journal of magnetic resonance imaging : JMRI, 2008, Volume: 28, Issue:2 Topics: Adult; Aged; Contrast Media; Female; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Imaging, Three-Dimensional; Liver Diseases; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds	2008
Quantitative and qualitative comparison of 1.5 and 3.0 Tesla MRI in patients with chronic liver diseases. Journal of magnetic resonance imaging : JMRI, 2009, Volume: 29, Issue:4 Topics: Adult; Aged; Aged, 80 and over; Artifacts; Chronic Disease; Contrast Media; Female; Gadolinium DTPA; Humans; Image Processing, Computer-Assisted; Liver Diseases; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Retrospective Studies; Statistics, Nonparametric	2009
Fluorine-18-FDG PET findings of focal eosinophilic liver disease: correlation with CT and/or MRI, laboratory, and pathologic findings. Abdominal imaging, 2010, Volume: 35, Issue:4 Topics: Adult; Aged; Alcohol Oxidoreductases; Contrast Media; Eosinophilia; Female; Fluorodeoxyglucose F18; Humans; Iohexol; Liver Diseases; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed	2010
Hepatobiliary-specific MR contrast agents: role in imaging the liver and biliary tree. Radiographics : a review publication of the Radiological Society of North America, Inc, 2009, Volume: 29, Issue:6 Topics: Bile Ducts; Contrast Media; Edetic Acid; Gadolinium DTPA; Humans; Image Enhancement; Liver; Liver Diseases; Magnetic Resonance Imaging; Meglumine; Organometallic Compounds; Pyridoxal Phosphate	2009
Potential conditions causing impairment of selective hepatobiliary enhancement of gadobenate dimeglumine-enhanced delayed magnetic resonance imaging. Journal of computer assisted tomography, 2010, Volume: 34, Issue:1 Topics: Alanine Transaminase; Alkaline Phosphatase; Aspartate Aminotransferases; Biliary Tract; Bilirubin; Blood Urea Nitrogen; Contrast Media; Creatinine; Female; Humans; Image Enhancement; Kidney Diseases; Liver; Liver Diseases; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Observer Variation; Organometallic Compounds; Retrospective Studies; Splenomegaly	2010
Solid focal liver lesions: dynamic and late enhancement patterns with the dual phase contrast agent gadobenate dimeglumine. Journal of gastrointestinal cancer, 2010, Volume: 41, Issue:4 Topics: Contrast Media; Humans; Image Enhancement; Liver Diseases; Magnetic Resonance Imaging; Meglumine; Organometallic Compounds	2010
Effect of gadolinium chelate contrast agents on diffusion weighted MR imaging of the liver, spleen, pancreas and kidney at 3 T. European journal of radiology, 2011, Volume: 80, Issue:2 Topics: Adult; Analysis of Variance; Contrast Media; Diffusion Magnetic Resonance Imaging; Echo-Planar Imaging; Female; Gadolinium DTPA; Humans; Kidney Diseases; Liver Diseases; Male; Meglumine; Middle Aged; Organometallic Compounds; Pancreatic Diseases; Retrospective Studies; Splenic Diseases	2011
Solid hypervascular liver lesions: accurate identification of true benign lesions on enhanced dynamic and hepatobiliary phase magnetic resonance imaging after gadobenate dimeglumine administration. Investigative radiology, 2011, Volume: 46, Issue:4 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Child; Contrast Media; Female; Humans; Liver Diseases; Liver Neoplasms; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds	2011
Hepatocellular MR contrast agents: enhancement characteristics of liver parenchyma and portal vein after administration of gadoxetic acid in comparison to gadobenate dimeglumine. European journal of radiology, 2012, Volume: 81, Issue:9 Topics: Adult; Aged; Contrast Media; Female; Gadolinium DTPA; Humans; Liver; Liver Diseases; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Portal Vein; Reproducibility of Results; Sensitivity and Specificity	2012
Quantifying differences in hepatic uptake of the liver specific contrast agents Gd-EOB-DTPA and Gd-BOPTA: a pilot study. European radiology, 2012, Volume: 22, Issue:3 Topics: Adult; Aged; Aged, 80 and over; Analysis of Variance; Contrast Media; Female; Gadolinium DTPA; Humans; Image Interpretation, Computer-Assisted; Liver; Liver Diseases; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Pilot Projects; Prospective Studies; Retrospective Studies; Spleen; Treatment Outcome	2012
Hepatic nodular regenerative lesions in patients with hereditary haemorrhagic telangiectasia: computed tomography and magnetic resonance findings. La Radiologia medica, 2013, Volume: 118, Issue:1 Topics: Adult; Angiography; Arteriovenous Malformations; Contrast Media; Dextrans; Female; Humans; Image Interpretation, Computer-Assisted; Liver; Liver Diseases; Liver Regeneration; Magnetic Resonance Imaging; Magnetite Nanoparticles; Male; Meglumine; Middle Aged; Organometallic Compounds; Prevalence; Retrospective Studies; Telangiectasia, Hereditary Hemorrhagic; Tomography, X-Ray Computed	2013
Liver-specific contrast agents. Cancer imaging : the official publication of the International Cancer Imaging Society, 2012, Sep-28, Volume: 12 Topics: Contrast Media; Gadolinium DTPA; Humans; Liver; Liver Diseases; Magnetic Resonance Imaging; Meglumine; Organometallic Compounds	2012
Contrast-enhanced sonography with SonoVue: enhancement patterns of benign focal liver lesions and correlation with dynamic gadobenate dimeglumine-enhanced MRI. AJR. American journal of roentgenology, 2005, Volume: 184, Issue:3 Topics: Adult; Aged; Aged, 80 and over; Contrast Media; Female; Humans; Liver Diseases; Liver Neoplasms; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Radiography; Ultrasonography	2005
In vivo assessment of the tolerance dose of small liver volumes after single-fraction HDR irradiation. International journal of radiation oncology, biology, physics, 2005, Jul-01, Volume: 62, Issue:3 Topics: Adult; Aged; Aged, 80 and over; Brachytherapy; Contrast Media; Dose-Response Relationship, Radiation; Edema; Female; Hepatocytes; Humans; Liver; Liver Diseases; Liver Neoplasms; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Prospective Studies; Radiation Tolerance	2005
Comparison of Gadolinium-BOPTA and Ferucarbotran-enhanced three-dimensional T1-weighted dynamic liver magnetic resonance imaging in the same patient. Investigative radiology, 2006, Volume: 41, Issue:3 Topics: Adult; Aged; Contrast Media; Dextrans; Female; Ferrosoferric Oxide; Humans; Imaging, Three-Dimensional; Iron; Liver Diseases; Magnetic Resonance Imaging; Magnetite Nanoparticles; Male; Meglumine; Middle Aged; Organometallic Compounds; Oxides; Prospective Studies; Sensitivity and Specificity	2006
Gadobenate dimeglumine-enhanced liver MRI as the sole preoperative imaging technique: a prospective study of living liver donors. AJR. American journal of roentgenology, 2006, Volume: 187, Issue:5 Topics: Adolescent; Adult; Biliary Tract; Biliary Tract Diseases; Contrast Media; Female; Hepatectomy; Hepatic Artery; Humans; Liver; Liver Diseases; Liver Transplantation; Living Donors; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Radiography; Sensitivity and Specificity	2006
High contrast enhancement of the liver in CT by repeated doses of contrast medium. European journal of radiology, 1981, Volume: 1, Issue:2 Topics: Adult; Diatrizoate Meglumine; Humans; Iodamide; Iodipamide; Liver Diseases; Liver Neoplasms; Male; Meglumine; Middle Aged; Radiographic Image Enhancement; Tomography, X-Ray Computed	1981
Differential diagnosis of focal liver lesions: role of spin-echo and contrast-enhanced dynamic MR imaging. Radiology, 1994, Volume: 193, Issue:1 Topics: Contrast Media; Diagnosis, Differential; Drug Combinations; Female; Gadolinium DTPA; Humans; Liver; Liver Diseases; Liver Neoplasms; Logistic Models; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Multivariate Analysis; Organometallic Compounds; Pentetic Acid; Retrospective Studies	1994
Dynamic contrast-enhanced MR imaging of the portal venous system: comparison with x-ray angiography. Radiology, 1994, Volume: 191, Issue:3 Topics: Adolescent; Adult; Child; Child, Preschool; Contrast Media; Drug Combinations; Female; Gadolinium DTPA; Humans; Liver Diseases; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Pentetic Acid; Portal Vein; Radiography; Splenic Vein	1994
Focal liver lesions: characterization with nonenhanced and dynamic contrast material-enhanced MR imaging. Radiology, 1994, Volume: 190, Issue:2 Topics: Adult; Aged; Aged, 80 and over; Contrast Media; Diagnosis, Differential; Drug Combinations; Female; Gadolinium DTPA; Humans; Liver; Liver Diseases; Liver Neoplasms; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Observer Variation; Organometallic Compounds; Pentetic Acid; Prospective Studies; ROC Curve; Sensitivity and Specificity	1994
Fast multiplanar spoiled gradient-recalled imaging of the liver: pulse sequence optimization and comparison with spin-echo MR imaging. AJR. American journal of roentgenology, 1993, Volume: 160, Issue:3 Topics: Adult; Aged; Carcinoma, Hepatocellular; Contrast Media; Cysts; Drug Combinations; Female; Gadolinium DTPA; Humans; Image Enhancement; Liver Diseases; Liver Neoplasms; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Pentetic Acid	1993
Aortic ghost artifact in ultrashort TE multislice gradient echo MR images is not increased by paramagnetic enhancement. Magnetic resonance in medicine, 1993, Volume: 29, Issue:2 Topics: Aorta, Abdominal; Artifacts; Contrast Media; Drug Combinations; Gadolinium; Gadolinium DTPA; Humans; Liver; Liver Diseases; Magnetic Resonance Imaging; Meglumine; Models, Cardiovascular; Models, Structural; Organometallic Compounds; Pentetic Acid; Pulsatile Flow; Time Factors	1993
Multicenter testing of gadobenate dimeglumine in magnetic resonance imaging of focal liver disease. Academic radiology, 1996, Volume: 3 Suppl 2 Topics: Contrast Media; Humans; Liver; Liver Diseases; Liver Neoplasms; Magnetic Resonance Imaging; Meglumine; Organometallic Compounds; Sensitivity and Specificity	1996
Gadolinium-enhanced MR imaging of the spleen: artifacts and potential pitfalls. AJR. American journal of roentgenology, 1996, Volume: 167, Issue:5 Topics: Aged; Artifacts; Contrast Media; Drug Combinations; Female; Gadolinium; Gadolinium DTPA; Humans; Image Enhancement; Liver; Liver Diseases; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Pentetic Acid; Spleen; Splenic Diseases	1996
Hepatic arterial-phase dynamic gadolinium-enhanced MR imaging: optimization with a test examination and a power injector. Radiology, 1997, Volume: 202, Issue:1 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Contrast Media; Drug Combinations; Female; Gadolinium; Gadolinium DTPA; Hepatic Artery; Humans; Injections; Liver; Liver Circulation; Liver Diseases; Liver Neoplasms; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Pentetic Acid; Portal Vein	1997
Hepatic lesion detection at MR imaging: a comparative study with four sequences. Radiology, 1997, Volume: 203, Issue:3 Topics: Adipose Tissue; Adult; Aged; Area Under Curve; Contrast Media; Drug Combinations; Female; Ferrosoferric Oxide; Gadolinium; Gadolinium DTPA; Hepatectomy; Humans; Image Enhancement; Image Processing, Computer-Assisted; Iron; Liver Diseases; Liver Neoplasms; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Observer Variation; Organometallic Compounds; Oxides; Pentetic Acid; Preoperative Care; ROC Curve; Sensitivity and Specificity; Single-Blind Method	1997
Characterization of focal hepatic masses by dynamic contrast-enhanced MR imaging: findings in 311 lesions. Magnetic resonance imaging, 1997, Volume: 15, Issue:3 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Carcinoma, Hepatocellular; Contrast Media; Cysts; Drug Combinations; Female; Follow-Up Studies; Gadolinium; Gadolinium DTPA; Hemangioma, Cavernous; Hepatic Artery; Humans; Image Enhancement; Injections, Intra-Arterial; Injections, Intravenous; Liver Diseases; Liver Neoplasms; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Pentetic Acid; Respiration; Retrospective Studies; Sensitivity and Specificity; Single-Blind Method	1997
Nontumorous hepatic pseudolesion around the falciform ligament: prevalence on gadolinium chelate-enhanced MR examination. AJR. American journal of roentgenology, 1997, Volume: 169, Issue:3 Topics: Adult; Aged; Aged, 80 and over; Contrast Media; Female; Gadolinium; Humans; Image Processing, Computer-Assisted; Ligaments; Liver; Liver Diseases; Liver Neoplasms; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Prospective Studies	1997
Perfusion-weighted MR imaging in the upper abdomen: preliminary clinical experience in 61 patients. AJR. American journal of roentgenology, 1997, Volume: 169, Issue:4 Topics: Abdomen; Adult; Aged; Contrast Media; Drug Combinations; Echo-Planar Imaging; Female; Gadolinium DTPA; Humans; Kidney; Liver Diseases; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Pancreatic Diseases; Pentetic Acid; Spleen	1997
Multihance clinical pharmacology: biodistribution and MR enhancement of the liver. Academic radiology, 1998, Volume: 5 Suppl 1 Topics: Contrast Media; Gadolinium; Humans; Liver; Liver Diseases; Magnetic Resonance Imaging; Male; Meglumine; Organometallic Compounds; Single-Blind Method	1998
Iosefamate meglumine: an iodinated contrast agent for hepatic computed tomography scanning. Radiology, 1979, Volume: 132, Issue:1 Topics: Animals; Chemical Phenomena; Chemistry; Dogs; Dose-Response Relationship, Drug; Iodipamide; Liver Diseases; Meglumine; Tomography, X-Ray Computed	1979
Magnetic resonance imaging contrast agents. Current opinion in radiology, 1992, Volume: 4, Issue:1 Topics: Abdomen; Animals; Brain Diseases; Contrast Media; Drug Combinations; Gadolinium; Gadolinium DTPA; Heterocyclic Compounds; Humans; Liver Diseases; Magnetic Resonance Imaging; Meglumine; Organometallic Compounds; Pentetic Acid; Spinal Diseases	1992